tiprankstipranks
Trending News
More News >

Medicenna Announces Breakthroughs in Cancer Treatment

Story Highlights
Medicenna Announces Breakthroughs in Cancer Treatment

Medicenna Therapeutics Corp (TSE:MDNA) has released an update.

Confident Investing Starts Here:

Medicenna Therapeutics Corp. has unveiled promising preclinical data from its BiSKIT and IL-2 Super Agonist programs, showcasing potential breakthroughs in cancer treatment. Their novel therapies, MDNA113 and MDNA11, have demonstrated significant tumor regression and survival benefits in aggressive cancer models, promising hope for millions affected by tumors worldwide.

For further insights into TSE:MDNA stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App